Combination of LBH589 with other therapeutic agents for treating cancer

Details for Australian Patent Application No. 2008216327 (hide)

Owner Novartis AG

Inventors Atadja, Peter Wisdom; Shao, Wenlin; Bhalla, Kapil N.

Agent Davies Collison Cave

Pub. Number AU-A-2008216327

PCT Pub. Number WO2008/100985

Priority 60/890,005 15.02.07 US

Filing date 13 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 31/00 (2006.01)

A61K 31/4045 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/100985 Priority application(s): WO2008/100985

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216349-Method and apparatus for conserving battery power

2008216318-Vortex induced vibration suppression systems and methods